Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine

Pharmaceutical Development and Technology

Volumn 15, Issue 4, 2010, Pages 431-437

  Kotagale, Nandkishor ^a   Maniyar, Mithun ^a   Somvanshi, Sachin ^a   Umekar, Milind ^a   Patel, Chirag J ^a  

^a India   (India)

Author keywords

azathioprine; cellulose acetate phthalate; Colon targeted drug delivery; eudragit l ^{< sup>; eudragit s < sup>; polysaccharide; rat cecal content}

Indexed keywords

AZATHIOPRINE; CELLACEFATE; CITRIC ACID; EUDRAGIT; INULIN; PLASTICIZER; POLYMER; POLYSACCHARIDE; TRIACETIN; CELLULOSE; DELAYED RELEASE FORMULATION; EXCIPIENT; IMMUNOSUPPRESSIVE AGENT; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; POLYMETHACRYLIC ACID DERIVATIVE; TABLET;

ARTICLE; CECUM; COLON; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG TARGETING; IN VITRO STUDY; NONHUMAN; PH; PRIORITY JOURNAL; RAT; TABLET; TABLET COMPRESSION; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; HARDNESS; METABOLISM; SOLUBILITY; WISTAR RAT;

ANIMALS; AZATHIOPRINE; CELLULOSE; COLON; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HARDNESS; HYDROGEN-ION CONCENTRATION; IMMUNOSUPPRESSIVE AGENTS; POLYMETHACRYLIC ACIDS; POLYSACCHARIDES; RATS; RATS, WISTAR; SOLUBILITY; TABLETS;

EID: 77953973088     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450903264401     Document Type: Article

References (32)

1. Bussemer T, Otto I, Bodmeier R. Pulsatile drug-delivery systems. Crit Rev Ther Drug Carrier Syst 2001;18:433-458.
2. Yang L, Chu J, Fix J. Colon specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharm 2002;235:1-15.
3. Friend DR. New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev 2005;57:247-265.
4. Friend DR. Colon specific drug delivery. Adv Drug Deliv Rev 1991;7:149-199.
5. Nunthanid J, Haunbutta K, Luangtana-Anan M, Sriamornsak P, Limmatvapirat S, Puttipipatkhachorn S. Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxyl methylcellulose. Eur J Pharm Biopharm 2008; 68(2):253-259.
6. Dandagi PM, Jain SS, Gadad AP, Mastiholimath VS, Kulkarni AR. Time and pH dependent colon specific, pulsatile delivery of theophylline for noctyrnal asthma. Int J Pharm 2007;328(1):49-56.
7. Sinha VR, Kumaria R. Binders for colon specific drug delivery: An in vitro evaluation. Int J Pharm 2002;249:23-31.
8. Pharia A, Yadav AK, Rai G, Jain SK, Pancholi SS, Agrawal GP. Eudragit-coated pectin microspheres of 5-flurouracil for colon targeting. AAPS PharmSCITech 2007;8(1):E1-7.
9. Fedorak RN, Bistritz L. Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide. Adv Drug Del Rev 2005;57:303-316.
10. Akhgari A, Garekani HA, Sadeghi F, Azimaie M. Statistical optimization of indomethacin pellets coated with pH dependent methacrylic polymers for possible colonic drug delivey. Int J Pharm 2005;305:22-30.
11. Ishibashi T, Ikegami K, Kubo H, Kobayashi M, Mizobe M, Yoshino H. Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC). J Control Rel 1999;59:361-376.
12. Nykanen P, Lempaa S, Aaltonen ML, Jurjenson H, Veski P, Marvola M. Citric acid as excipient in multiple-unit entericcoated tablets for targeting drugs on the colon. Int J Pharm 2001;229:155-162.
13. Meissner Y, Ubrich N, Ghazouani F, Maincent P, Lamprecht A. Low molecular weight heparin loaded pH-sensitive micoparticles. J Pharm 2007;335:147-153.
14. Chaurasia M, Chourasia MK, Jain NK et al, Jain A, Soni V, Gupta Y, Jain SK. Cross-linked guar gum microspheres: A viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. AAPS PharmSciTech 2006;7(3):Article 74.
15. Nagamitsu A, Konno T, Oda T, Tabaru K, Ishimaru Y, Kitamura N. Targeted cancer chemotherapy for VX2 tumour implanted in the colon with lipiodol as a carrier. Eur J Cancer 1998;34(11):1764-1769.
16. Koning GA, Kamps JAAM, Scherphof GL. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes. Cancer Det Prevent 2002;26: 299-307.
17. Schiffelers RM, Koning GA, ten Hagen TL, Fens MH, Schraa AJ, Janssen AP, et al. Anti-tumor efficacy of tumor vasculature- targeted liposomal doxorubicin. J Control Rel 2003;91:115-122.
18. Shimizu K, Asai T, Fuse C, Sadzuka Y, Sonobe T, Ogino K, et al. Applicability of anti-neovascular therapy to drug-resistant tumor: Suppression of drug-resistant P388 tumor growth with neovessel-targeted liposomal adriamycin. Int J Pharm 2005;296(1-2):133-141.
19. Zahirul M, Khan I, Prebeg Z, Kurjakovih N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit™ L100-55 and Eudragit™ S 100 combinations. J Control Rel 1999;58:215-222.
20. Fukui E, Miyamura N, Kobayashi M. An in vivo investigation of presscoated tablets with Hydroxypropylethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shells for colon targeting. J Control Rel 2001;70:97-107.
21. Sinha VR, Kumaria R. Polysaccharide matrices for microbially triggered drug delivery to the colon. Drug Dev Ind Pharm 2004;30(2):143-150.
22. Liu H, Yang XG, Nie SF, Wei LL, Zhou LL, Liu H, Tang R, Pan WS. Chitosan-based controlled porosity pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation. Int J Pharm 2007;332:115-124.
23. Tozaki H, Komotke J, Tada C et al. Chitosan capsules for colonspecific drug delivery: Improvement of insulin absorption from the rat colon. J Pharm Sci 1997;86:1016-1021.
24. Sinha VR, Mithal BR, Kumaria R. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int J Pharm 2005;289:79-85.
25. Dhaneshwar SS, Gairola N, Kandpal M, Bhatt L, Vadnerkar G, Kadam SS. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease. Bio Med Chem Let 2007;17:1897-1902. (Pubitemid 46367669)
26. Chavan MS, Sant VP, Nagarsenker MS. Azo-containing urethane analogues for colonic drug delivery: Synthesis, characterisation and in vitro evaluation. J Pharm Pharmacol 2001;53:895-900.
27. Sakuma S, Lu ZR, Kopeckova P, Kopecek J. Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin. J Control Rel 2001;75:365-379.
28. Davaran S, Hanaee J, Khosravi A. Release of 5-amino salicylic acid from acrylic type polymeric prodrugs designed for colonspecific drug delivery. J Control Rel 1999;58:279-287.
29. Bruce LD, Shah NH, Malick AW, Infeld MH, McGinity JW. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid. Eur J Pharm Biopharm 2005; 59(1):85-97.
30. Sinha VR, Kumaria R. Polysaccharides in colon-specific drug delivery. Int J Pharm 2001;224:19-38.
31. Rowe RC, Sheskey PJ, Owen CS. Citric acid monohydrate. Handbook of pharmaceutical excipients. 4th ed. London: Pharmaceutical Press; 2000:478-482.
32. Van den Mooter G, Vervoort L, Kinget R. Characterization of methacrylated inulin hyrdrogels designed for colon targeting: In vitro release of BSA. Pharm Res 2003;20:303-307.